NO20060229L - Gaboxadol for behandling av depresjon og andre affektive lidelser - Google Patents
Gaboxadol for behandling av depresjon og andre affektive lidelserInfo
- Publication number
- NO20060229L NO20060229L NO20060229A NO20060229A NO20060229L NO 20060229 L NO20060229 L NO 20060229L NO 20060229 A NO20060229 A NO 20060229A NO 20060229 A NO20060229 A NO 20060229A NO 20060229 L NO20060229 L NO 20060229L
- Authority
- NO
- Norway
- Prior art keywords
- gaboxadol
- depression
- treatment
- affective disorders
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200300956 | 2003-06-25 | ||
DKPA200400016 | 2004-01-07 | ||
PCT/DK2004/000459 WO2004112786A2 (en) | 2003-06-25 | 2004-06-25 | Gaboxadol for treating depression and other affective disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20060229L true NO20060229L (no) | 2006-01-16 |
Family
ID=58707228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20060229A NO20060229L (no) | 2003-06-25 | 2006-01-16 | Gaboxadol for behandling av depresjon og andre affektive lidelser |
Country Status (10)
Country | Link |
---|---|
KR (1) | KR20060025192A (es) |
AR (1) | AR047550A1 (es) |
CA (2) | CA2692334A1 (es) |
CL (2) | CL2004001607A1 (es) |
EA (1) | EA200600101A1 (es) |
IS (1) | IS8138A (es) |
ME (2) | ME00030B (es) |
NO (1) | NO20060229L (es) |
RS (1) | RS20050911A (es) |
TW (1) | TW200509918A (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020106927A1 (en) | 2018-11-21 | 2020-05-28 | Certego Therapeutics | Gaboxadol for reducing risk of suicide and rapid relief of depression |
IL298334A (en) | 2020-05-20 | 2023-01-01 | Certego Therapeutics Inc | A canceled gaboxadol ring and its use for the treatment of psychiatric disorders |
-
2004
- 2004-06-15 TW TW093117156A patent/TW200509918A/zh unknown
- 2004-06-23 AR ARP040102200A patent/AR047550A1/es not_active Application Discontinuation
- 2004-06-24 CL CL200401607A patent/CL2004001607A1/es unknown
- 2004-06-25 ME MEP-2008-19A patent/ME00030B/me unknown
- 2004-06-25 CA CA2692334A patent/CA2692334A1/en not_active Abandoned
- 2004-06-25 EA EA200600101A patent/EA200600101A1/ru unknown
- 2004-06-25 KR KR1020057024823A patent/KR20060025192A/ko not_active Application Discontinuation
- 2004-06-25 CA CA002529805A patent/CA2529805A1/en not_active Abandoned
- 2004-06-25 RS YUP-2005/0911A patent/RS20050911A/sr unknown
- 2004-06-25 ME MEP-19/08A patent/MEP1908A/xx unknown
-
2005
- 2005-11-21 IS IS8138A patent/IS8138A/is unknown
-
2006
- 2006-01-16 NO NO20060229A patent/NO20060229L/no not_active Application Discontinuation
-
2010
- 2010-02-25 CL CL2010000166A patent/CL2010000166A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CL2010000166A1 (es) | 2010-07-02 |
CA2529805A1 (en) | 2004-12-29 |
TW200509918A (en) | 2005-03-16 |
RS20050911A (en) | 2007-08-03 |
MEP1908A (xx) | 2010-02-10 |
CA2692334A1 (en) | 2004-12-29 |
AR047550A1 (es) | 2006-01-25 |
IS8138A (is) | 2005-11-21 |
EA200600101A1 (ru) | 2006-06-30 |
CL2004001607A1 (es) | 2005-05-27 |
ME00030B (me) | 2010-06-10 |
KR20060025192A (ko) | 2006-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20060242L (no) | Kombinasjonen av en serotonin-reopptaksinhibitor og agomelatin | |
EA201190217A1 (ru) | Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение | |
IL202106A0 (en) | Gaboxadol for treating depression and other affective disorders | |
NO20082026L (no) | Deazapuriner som er nyttige som inhibitorer for Janus-kinaser | |
EA201101190A1 (ru) | Фармацевтическая композиция, включающая линаглиптин и необязательно ингибитор sglt2, и ее применение | |
EA200700035A1 (ru) | Сульфаматные и сульфамидные производные для лечения эпилепсии и родственных di sorders | |
EA201370208A1 (ru) | Формы рифаксимина и их применение | |
EA200601553A1 (ru) | Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды | |
EA200901032A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
EA200970337A1 (ru) | Ингибиторы котранспортера натрий-глюкозы 2 и способы их применения | |
NO20083501L (no) | Azaindoler som er anvendelige som inhibitorer for Janus-kinaser | |
EA201100138A1 (ru) | 4-феноксиметилпиперидины в качестве модуляторов активности gpr119 | |
EA200970581A1 (ru) | Кристаллическое твёрдое основание разагилина | |
NO20064976L (no) | Azanidoler som er nyttige som inhibitorer av rock og andre proteinkinaser | |
NO20060402L (no) | 3-amino choman og 2-aminotetralinderivater | |
DK1937669T3 (da) | Nye benzopyranderivater som kaliumkanalåbnere | |
BRPI0508254A (pt) | métodos e composições para o tratamento ou prevenção de distúrbios psiquiátricos com inibidores de cox-2 sozinhos e em combinação com agentes antidepressivos | |
EA201070327A1 (ru) | Катехоламиновые производные и их пролекарства | |
EA200702253A1 (ru) | Фармацевтическая композиция | |
EA201001747A1 (ru) | Бензоксазиноновые производные, действующие в качестве агониста бета-2-адренорецептора, для лечения респираторных расстройств | |
CL2008003231A1 (es) | Compuestos derivados de 1,3-dihidro-5-isobenzofurancarbonitrilo sustituido, inhibidores selectivos de la recaptacion de serotonina; composicion farmaceutica; procedimiento de preparacion; utiles en el tratamiento y/o prevencion de la eyaculacion prematura. | |
NO20076405L (no) | Anvendelse av 24-nor-UDCA | |
NO20083751L (no) | Metoder for behandling av kognitive og andre sykdommer | |
ATE440836T1 (de) | Verbindungen | |
ATE524463T1 (de) | 4-chromenonyl-1,4-dihydropyridincarbonitrile und ihre verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CREP | Change of representative |
Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104 |
|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |